FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W83501350> ?p ?o ?g. }

• W83501350 endingPage "57" @default.
• W83501350 startingPage "46" @default.
• W83501350 abstract "Chronic lymphocytic leukemia (CLL) development and progression are thought to be driven by unknown antigens/autoantigens through the B cell receptor (BCR) and environmental signals for survival and expansion including toll-like receptor (TLR) ligands. CD180/RP105, a membrane-associated orphan receptor of the TLR family, induces normal B cell activation and proliferation and is expressed by approximately 60% of CLL samples. Half of these respond to ligation with anti-CD180 antibody by increased activation/phosphorylation of protein kinases associated with BCR signaling. Hence CLL cells expressing both CD180 and the BCR could receive signals via both receptors. Here we investigated cross-talk between BCR and CD180-mediated signaling on CLL cell survival and apoptosis. Our data indicate that ligation of CD180 on responsive CLL cells leads to activation of either prosurvival Bruton tyrosine kinase (BTK)/phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT-mediated, or proapoptotic p38 mitogenactivated protein kinase (p38MAPK)-mediated signaling pathways, while selective immunoglobulin M (sIgM) ligation predominantly engages the BTK/PI3K/AKT pathway. Furthermore, pretreatment of CLL cells with anti-CD180 redirects IgM-mediated signaling from the prosurvival BTK/PI3K/AKT toward the proapoptotic p38MAPK pathway. Thus preengaging CD180 could prevent further prosurvival signaling mediated via the BCR and, instead, induce CLL cell apoptosis, opening the door to therapeutic profiling and new strategies for the treatment of a substantial cohort of CLL patients." @default.
• W83501350 created "2016-06-24" @default.
• W83501350 creator A5004809714 @default.
• W83501350 creator A5015977621 @default.
• W83501350 creator A5027884503 @default.
• W83501350 creator A5032635874 @default.
• W83501350 creator A5040500242 @default.
• W83501350 creator A5043592767 @default.
• W83501350 creator A5052485795 @default.
• W83501350 creator A5063213512 @default.
• W83501350 creator A5064797858 @default.
• W83501350 creator A5078090532 @default.
• W83501350 creator A5088137199 @default.
• W83501350 creator A5091781039 @default.
• W83501350 date "2015-01-01" @default.
• W83501350 modified "2023-10-18" @default.
• W83501350 title "Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor" @default.
• W83501350 cites W1481723694 @default.
• W83501350 cites W1499230593 @default.
• W83501350 cites W1551637714 @default.
• W83501350 cites W1574031913 @default.
• W83501350 cites W1580727454 @default.
• W83501350 cites W1629371507 @default.
• W83501350 cites W1874310950 @default.
• W83501350 cites W1968497562 @default.
• W83501350 cites W1971408160 @default.
• W83501350 cites W1972593274 @default.
• W83501350 cites W1973570387 @default.
• W83501350 cites W1978432163 @default.
• W83501350 cites W1983579522 @default.
• W83501350 cites W1984621921 @default.
• W83501350 cites W1986122954 @default.
• W83501350 cites W1988046098 @default.
• W83501350 cites W1990033869 @default.
• W83501350 cites W1991216047 @default.
• W83501350 cites W1992572858 @default.
• W83501350 cites W1993192840 @default.
• W83501350 cites W1994990929 @default.
• W83501350 cites W1999338173 @default.
• W83501350 cites W1999532069 @default.
• W83501350 cites W2005634587 @default.
• W83501350 cites W2006777007 @default.
• W83501350 cites W2011950935 @default.
• W83501350 cites W2013217534 @default.
• W83501350 cites W2025755006 @default.
• W83501350 cites W2025786205 @default.
• W83501350 cites W2025862464 @default.
• W83501350 cites W2027971058 @default.
• W83501350 cites W2032553162 @default.
• W83501350 cites W2036758696 @default.
• W83501350 cites W2050403940 @default.
• W83501350 cites W2061249695 @default.
• W83501350 cites W2066027952 @default.
• W83501350 cites W2075875145 @default.
• W83501350 cites W2081270623 @default.
• W83501350 cites W2081457656 @default.
• W83501350 cites W2081994535 @default.
• W83501350 cites W2082143240 @default.
• W83501350 cites W2089604938 @default.
• W83501350 cites W2093508027 @default.
• W83501350 cites W2093577878 @default.
• W83501350 cites W2095414285 @default.
• W83501350 cites W2098166849 @default.
• W83501350 cites W2099909147 @default.
• W83501350 cites W2099944032 @default.
• W83501350 cites W2114847222 @default.
• W83501350 cites W2116468952 @default.
• W83501350 cites W2117510681 @default.
• W83501350 cites W2120253175 @default.
• W83501350 cites W2120929679 @default.
• W83501350 cites W2124142977 @default.
• W83501350 cites W2126440988 @default.
• W83501350 cites W2129374292 @default.
• W83501350 cites W2143790526 @default.
• W83501350 cites W2144474266 @default.
• W83501350 cites W2148795397 @default.
• W83501350 cites W2155135145 @default.
• W83501350 cites W2159219386 @default.
• W83501350 cites W2165635618 @default.
• W83501350 cites W2172019913 @default.
• W83501350 cites W2245415865 @default.
• W83501350 cites W2418478757 @default.
• W83501350 cites W51210568 @default.
• W83501350 doi "https://doi.org/10.2119/molmed.2014.00265" @default.
• W83501350 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4461575" @default.
• W83501350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25611435" @default.
• W83501350 hasPublicationYear "2015" @default.
• W83501350 type Work @default.
• W83501350 sameAs 83501350 @default.
• W83501350 citedByCount "9" @default.
• W83501350 countsByYear W835013502015 @default.
• W83501350 countsByYear W835013502016 @default.
• W83501350 countsByYear W835013502017 @default.
• W83501350 countsByYear W835013502019 @default.
• W83501350 countsByYear W835013502021 @default.
• W83501350 countsByYear W835013502022 @default.
• W83501350 countsByYear W835013502023 @default.
• W83501350 crossrefType "journal-article" @default.

• next